» Articles » PMID: 37833788

Pan-cancer Spatially Resolved Single-cell Analysis Reveals the Crosstalk Between Cancer-associated Fibroblasts and Tumor Microenvironment

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2023 Oct 14
PMID 37833788
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer-associated fibroblasts (CAFs) are a heterogeneous cell population that plays a crucial role in remodeling the tumor microenvironment (TME). Here, through the integrated analysis of spatial and single-cell transcriptomics data across six common cancer types, we identified four distinct functional subgroups of CAFs and described their spatial distribution characteristics. Additionally, the analysis of single-cell RNA sequencing (scRNA-seq) data from three additional common cancer types and two newly generated scRNA-seq datasets of rare cancer types, namely epithelial-myoepithelial carcinoma (EMC) and mucoepidermoid carcinoma (MEC), expanded our understanding of CAF heterogeneity. Cell-cell interaction analysis conducted within the spatial context highlighted the pivotal roles of matrix CAFs (mCAFs) in tumor angiogenesis and inflammatory CAFs (iCAFs) in shaping the immunosuppressive microenvironment. In patients with breast cancer (BRCA) undergoing anti-PD-1 immunotherapy, iCAFs demonstrated heightened capacity in facilitating cancer cell proliferation, promoting epithelial-mesenchymal transition (EMT), and contributing to the establishment of an immunosuppressive microenvironment. Furthermore, a scoring system based on iCAFs showed a significant correlation with immune therapy response in melanoma patients. Lastly, we provided a web interface ( https://chenxisd.shinyapps.io/pancaf/ ) for the research community to investigate CAFs in the context of pan-cancer.

Citing Articles

Quantifying and interpreting biologically meaningful spatial signatures within tumor microenvironments.

Jing S, Wang H, Lin P, Yuan J, Tang Z, Li H NPJ Precis Oncol. 2025; 9(1):68.

PMID: 40069556 PMC: 11897387. DOI: 10.1038/s41698-025-00857-1.


High-dimensional deconstruction of HNSC reveals clinically distinct cellular states and ecosystems that are associated with prognosis and therapy response.

Xiao L, Shen Z, Pan Z, Qiu Y, Huang D, Liu Y J Transl Med. 2025; 23(1):254.

PMID: 40025504 PMC: 11872339. DOI: 10.1186/s12967-025-06299-4.


LOX iCAFs in HNSCC have the potential to predict prognosis and immunotherapy responses revealed by single cell RNA sequencing analysis.

Liu X, Li H, Wang Y, Zhang Q, Liu Y, Liu T Sci Rep. 2025; 15(1):7028.

PMID: 40016474 PMC: 11868481. DOI: 10.1038/s41598-025-91036-6.


Cancer-associated fibroblasts in hepatocellular carcinoma: heterogeneity, mechanisms and therapeutic targets.

Li Y, Hamad M, Elkord E Hepatol Int. 2025; .

PMID: 39979756 DOI: 10.1007/s12072-025-10788-5.


Small Fish, Big Answers: Zebrafish and the Molecular Drivers of Metastasis.

Martinez-Lopez M, Lopez-Gil J Int J Mol Sci. 2025; 26(3).

PMID: 39940643 PMC: 11817282. DOI: 10.3390/ijms26030871.


References
1.
Li Y, Jin J, Bai F . Cancer biology deciphered by single-cell transcriptomic sequencing. Protein Cell. 2021; 13(3):167-179. PMC: 8901819. DOI: 10.1007/s13238-021-00868-1. View

2.
Xu M, Zhang T, Xia R, Wei Y, Wei X . Targeting the tumor stroma for cancer therapy. Mol Cancer. 2022; 21(1):208. PMC: 9628074. DOI: 10.1186/s12943-022-01670-1. View

3.
Chhabra Y, Weeraratna A . Fibroblasts in cancer: Unity in heterogeneity. Cell. 2023; 186(8):1580-1609. PMC: 11422789. DOI: 10.1016/j.cell.2023.03.016. View

4.
Pei L, Liu Y, Liu L, Gao S, Gao X, Feng Y . Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers. Mol Cancer. 2023; 22(1):29. PMC: 9912573. DOI: 10.1186/s12943-023-01731-z. View

5.
Tsoumakidou M . The advent of immune stimulating CAFs in cancer. Nat Rev Cancer. 2023; 23(4):258-269. DOI: 10.1038/s41568-023-00549-7. View